← Back to headlines
EU Regulator Recommends Approval for Sanofi's Subcutaneous Blood Cancer Drug Scarlisa
The European Union regulator has given its backing to Sanofi's injectable version of a blood cancer drug, specifically recommending approval for the subcutaneous version of Scarlisa (isatuximab).
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
seeking-alphaFrench1h ago
Sanofi gains EU approval recommendation for Scarlisa subcutaneous version
Read full article →ReutersFrench3h ago
EU regulator backs Sanofi's injectable version of blood cancer drug - Reuters
EU regulator backs Sanofi's injectable version of blood cancer drug Reuters
Read full article →Coverage Timeline
First report: Reuters · 27 Mar, 13:36|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
Related Stories
Manila Water Foundation Promotes Oral Health and Hygiene in Communities
just now
UK Advises Parents to Limit Screen Time for Under-Fives to One Hour
8m ago
Saba Azad Hospitalized with Parasitic Infection, Credits Hrithik Roshan for Support
9m ago
Greek National Public Health Organization Strengthens Epidemiological Surveillance
10m ago